Information  X 
Enter a valid email address

Summit Germany Ltd (SMTG)

  Print      Mail a friend

Friday 07 December, 2018

Summit Germany Ltd

Result of Buy-back and total voting rights

RNS Number : 8586J
Summit Germany Limited
07 December 2018
 

 

 

Summit Germany Limited

 

(the "Company")

 

Result of Buy-back and total voting rights

 

Summit Germany Limited is pleased to announce that, further to its announcement on 3 December 2018, the Buy-back was fully taken up. The Company has repurchased and cancelled 8,119,658 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at a purchase price of €1.17 per Ordinary Share, returning €9.5 million to shareholders in accordance with the approval granted by shareholders at the general meeting of the Company held on 18 July 2018.

 

Total voting rights

 

Following completion of the Buy-back, the Company has 457,280,204 Ordinary Shares in issue and admitted to trading on AIM with no Ordinary Shares in treasury. The number of Ordinary Shares in issue and the figure to be used as the denominator for calculations of interests in the Company's voting rights, is 457,280,204 Ordinary Shares.

 

Capitalised terms not otherwise defined in this announcement shall have the meaning given to them in the announcement of 3 December 2018.

 

For further information please contact:

Summit Germany Limited

Tel: +44 (0) 1481 700 300


Zohar Levy - Managing Director



Itay Barlev (Braun) - Finance Director






Non-Executive Chairman

Tel: +44 (0) 20 7451 7050


Harry Hyman






Carey, Company Secretary

Tel: +44 (0) 1481 700 300


Sara Bourne






Liberum Capital Limited, Nominated Adviser and Joint Broker

Tel: +44 (0) 20 3100 2222


Chris Clarke / Gillian Martin / Owen Matthews






Cenkos Securities, Joint Broker

Tel: +44 (0) 20 7397 8900


Mark Connelly



Russell Kerr / Selwyn Jones (Broking)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCTRBITMBMMBBP

a d v e r t i s e m e n t